type 2 diabetes

J&J touts NEJM publication of 5-year Type II diabetes bariatric surgery study
Mass Device
Fri, 02/17/17 - 09:57 am
JNJ
Ethicon
devices
type 2 diabetes
bariatric surgery
FDA Clears New Tool for Patients with Type 2 Diabetes
Qmed
Thu, 12/15/16 - 10:18 am
diabetes
FDA
JNJ
type 2 diabetes
LifeScan
blood glucose monitoring
WellDoc
Lilly Shares Spike On Jardiance Approval (LLY)
Investopedia
Sat, 12/3/16 - 12:04 am
Eli Lilly
FDA
Jardiance
type 2 diabetes
cardiovascular death
Johnson & Johnson Gets FDA Approval for Type 2 Diabetes Drug
Market Realist
Mon, 09/26/16 - 09:58 am
JNJ
FDA
type 2 diabetes
diabetes
Invokamet XR
Janssen
U.S. FDA expands indication for type 2 diabetes treatment Synjardy to include treatment-naïve adults
Yahoo
Wed, 07/20/16 - 02:25 pm
diabetes
Synjardy
type 2 diabetes
New Jardiance® (empagliflozin) data show that reduced risk for cardiovascular (CV) death was consistent across age groups in adults with type 2 diabetes
Yahoo
Sun, 06/12/16 - 09:56 pm
type 2 diabetes
Jardiance
Eli Lilly
Boehringer Ingelheim
AstraZeneca Presents New Data from Multiple Studies on the Effect of BYDUREON on Glucose Fluctuations in Patients with Type 2 Diabetes
Yahoo
Sun, 06/12/16 - 12:29 pm
AstraZeneca
Bydureon
clinical trials
diabetes
type 2 diabetes
Diabetes 'Unicorn' Intarcia Hits Major Milestone
Fortune
Fri, 05/6/16 - 10:33 am
Intarcia
diabetes
type 2 diabetes
IPOs
ITCA 650
Zafgen Soars on Positive Phase 2 Results
24/7 Wall St
Thu, 02/18/16 - 09:42 am
Zafgen
clinical trials
beloranib
obesity
type 2 diabetes
Sanofi Reports Positive Top-Line Results in Second Pivotal LixiLan Phase III Study
Yahoo
Mon, 09/14/15 - 08:46 am
Sanofi
LixiLan-L
type 2 diabetes
Bad News Type 2 Diabetics: The FDA Is Out With Another Warning
Motley Fool
Mon, 09/7/15 - 11:38 am
FDA
type 2 diabetes
DPP-4 inhibitor
SGLT2 inhibitor
Intarcia’s diabetes treatment beats $6B Merck drug in head-to-head trial
Bizjournals.com
Tue, 08/18/15 - 09:26 pm
Intarcia
Merck
diabetes
type 2 diabetes
devices
ITCA 650
Januvia
Sanofi's diabetes combo clears a clinical hurdle in a race with Novo Nordisk
Fierce Biotech
Wed, 07/29/15 - 09:51 pm
Sanofi
diabetes
type 2 diabetes
LixiLan
Boston's Intarcia now one step closer to upending type 2 diabetes market
Bizjournals.com
Mon, 06/8/15 - 11:23 am
Intarcia
type 2 diabetes
diabetes
ITCA 650
devices
Novo Nordisk type 2 diabetes combo drug tops Sanofi's Lantus -study
Yahoo/Reuters
Sun, 06/7/15 - 10:03 am
Novo Nordisk
type 2 diabetes
Sanofi
IDegLira
Lantus
FDA warns on newer class of type 2 diabetes drugs
Yahoo/Reuters
Sat, 05/16/15 - 02:04 pm
FDA
diabetes
type 2 diabetes
AstraZeneca
Farxiga
Eli Lilly
Jardiance
Boehringer Ingelheim
JNJ
Invokana
SGLT2 inhibitor
Isis Pharma Time Shifts Diabetes Drug Trial to Embellish Results
TheStreet.com
Tue, 02/3/15 - 10:45 am
Isis Pharmaceuticals
diabetes
type 2 diabetes
ISIS-PTP1B
FDA approves Boehringer-Lilly drug for type-2 diabetes patients
Yahoo/Reuters
Mon, 02/2/15 - 11:01 am
FDA
Eli Lilly
Boehringer Ingelheim
diabetes
type 2 diabetes
Glyxambi
FDA Label May Prevent Use of Metformin in Type 2 Diabetics
Drug Discovery and Development
Thu, 01/8/15 - 08:22 am
FDA
type 2 diabetes
metformin
Novo Nordisk's Victoza receives positive opinion for use in adults with type 2 diabetes
Reuters
Fri, 11/21/14 - 10:41 am
Novo Nordisk
type 2 diabetes
diabetes
Victoza

Pages